Several agents used for treatment of colon and other cancers induce reactive oxygen species
(ROS), and this plays an important role in their anticancer activities. In addition to the well-…

… Comparing with the normal counterparts, cancer cells generate more reactive oxygen
species (ROS). Therefore, it is possible that a higher level of ROS inducing cancer cell death …

… Colorectal cancer is a disease associated with a high mortality rate. During the … modify
cancer proliferation and metastasis. These regulatory agents include reactive oxygen species (…

… of colon cancer development. The present study investigates whether ROS production by
whole blood may contribute to the etiology of colorectal cancer (CRC). Whole–blood oxygen …

Background: The antibody cetuximab, targeting epidermal growth factor receptor (EGFR), is
used to treat metastatic colorectal cancer (mCRC). Clinical trials suggest reduced benefit …

Reactive oxygen species (ROS) are produced by mitochondria during metabolism. In
physiological states, the production of ROS and their elimination by antioxidants are kept in …

… Therefore, significant effort has been exerted to identify novel drug targets to reduce incidence
and malignancy of colorectal cancer cells. Reactive oxygen species (ROS), which are the …

… cancer cells. To explore the potential mechanisms that salinomycin could specifically target
on therapy-resistant cancer cells in colorectal cancers, … an original colorectal cancer cell line. …

… are found in a colorectal cancer-derived metastatic cell line (… their functional roles in colorectal
cancer metastasis. Molecular and … migration and invasion of colorectal cancer cells. Taken …

… has the genetic potential to drive colorectal cancer onset and progression; however, the …
-damaging reactive oxygen species, which drive colorectal cancer, is compromised in cancer. …